Among the biomarkers of lipid oxidation and inflammation, POMx supplementation significantly reduced MDA and HNE only in T2DM patients, while oxidized LDL and serum CRP were not significantly affected at 4 weeks in either group. This evidence concerns the gene CRP and type 2 diabetes mellitus.